Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities

被引:36
作者
Chandra, Girish [1 ,2 ]
Moon, Yang Won [3 ]
Lee, Yoonji [3 ]
Jang, Ji Yong [3 ]
Song, Jayoung [1 ]
Nayak, Akshata [1 ]
Oh, Kawon [1 ,3 ]
Mulamoottil, Varughese A. [3 ]
Sahu, Pramod K. [1 ]
Kim, Gyudong [1 ]
Chang, Tong-Shin [3 ]
Noh, Minsoo [1 ]
Lee, Sang Kook [1 ]
Choi, Sun [3 ]
Jeong, Lak Shin [1 ]
机构
[1] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 151742, South Korea
[2] Cent Univ Bihar, Sch Chem & Phys Sci, Dept Chem, Gaya 823001, Bihar, India
[3] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul 120750, South Korea
基金
新加坡国家研究基金会;
关键词
L-HOMOCYSTEINE HYDROLASE; STEREOSELECTIVE-SYNTHESIS; CARBOCYCLIC NUCLEOSIDES; BIOLOGICAL EVALUATION; MECHANISM; DESIGN; POTENT;
D O I
10.1021/acs.jmedchem.5b00553
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On the basis of the potent inhibitory activity of neplanocin A (1) against S-adenosylhomocysteine (AdoHcy) hydrolase, we analyzed the comprehensive structure-activity relationships by modifying the adenine and carbasugar moiety of 1 to find the pharmacophore in the active site of the enzyme. The introduction of 7-deazaadenine instead of adenine eliminated the inhibitory activity against the AdoHcy hydrolase, while 3-deazaadenine maintained the inhibitory activity of the enzyme, indicating that N-7 is essential for its role as a hydrogen bonding acceptor. The substitution of hydrogen at the 6'-position with fluorine increased the inhibitory activity Of the enzyme. The one-carbon homologation at the 5'-position generally decreased the inhibitory activity of the enzyme, indicating that steric repulsion exists. A molecular docking study also supported these experimental data. In this study, 6'-fluoroneplanocin A (2) was the most potent inhibitor of AdoHcy hydrolase (IC50 = 0.24 mu M). It showed a potent anti-VSV activity (EC50 = 0.43 mu M) and potent anticancer activity in all the human tumor cell lines tested.
引用
收藏
页码:5108 / 5120
页数:13
相关论文
共 31 条
[1]   Hydroxy group directivity in the epoxidation of chiral allylic alcohols: Control of diastereoselectivity through allylic strain and hydrogen bonding [J].
Adam, W ;
Wirth, T .
ACCOUNTS OF CHEMICAL RESEARCH, 1999, 32 (08) :703-710
[2]   Synthesis and antiviral activity of 7-deazaneplanocin A against orthopoxviruses (vaccinia and cowpox virus) [J].
Arumugham, B ;
Kim, HJ ;
Prichard, MN ;
Kern, ER ;
Chu, CK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) :285-287
[3]  
Borchardt R.T., 1986, BIOL METHYLATION DRU
[4]  
Cantoni G.L., 1986, Biological Methylation and Drug Design, P227
[5]   Stereoselective Synthesis of Fluoro-homoneplanocin A as a Potential Antiviral Agent [J].
Chandra, Girish ;
Majik, Mahesh S. ;
Lee, Ji Yee ;
Jeong, Lak Shin .
ORGANIC LETTERS, 2012, 14 (08) :2134-2137
[6]   Preparative and stereoselective synthesis of the versatile intermediate for carbocyclic nucleosides: Effects of the bulky protecting groups to enforce facial selectivity [J].
Choi, WJ ;
Moon, HR ;
Kim, HO ;
Yoo, BN ;
Lee, JA ;
Shin, DH ;
Jeong, LS .
JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (07) :2634-2636
[7]  
Chu C. K., 2009, U.S. Patent, Patent No. [0270431A1, 0270431]
[8]   Structure-activity relationship of heterobase-modified 2′-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication [J].
Eldrup, AB ;
Prhavc, M ;
Brooks, J ;
Bhat, B ;
Prakash, TP ;
Song, QL ;
Bera, S ;
Bhat, N ;
Dande, P ;
Cook, PD ;
Bennett, CF ;
Carroll, SS ;
Ball, RG ;
Bosserman, M ;
Burlein, C ;
Colwell, LF ;
Fay, JF ;
Flores, OA ;
Getty, K ;
LaFemina, RL ;
Leone, J ;
MacCoss, M ;
McMasters, DR ;
Tomassini, JE ;
Von Langen, D ;
Wolanski, B ;
Olsen, DB .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (21) :5284-5297
[9]   SUBSTRATE-DIRECTABLE CHEMICAL-REACTIONS [J].
HOVEYDA, AH ;
EVANS, DA ;
FU, GC .
CHEMICAL REVIEWS, 1993, 93 (04) :1307-1370
[10]   Chemical and biochemical transformations in ionic liquids [J].
Jain, N ;
Kumar, A ;
Chauhan, S ;
Chauhan, SMS .
TETRAHEDRON, 2005, 61 (05) :1015-1060